SCHEMBL10167491

SCHEMBL10167491

CN(C(=O)c1ccccc1)c1nsc2cccc(OC(F)F)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
TP53 P04637 2/20 0.40
NPC1 O15118 1/20 0.40
CASP3 P42574 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
KMT2A Q03164 4/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
NR1H2 P55055 1/20 0.35
NR1H3 Q13133 1/20 0.35
HCRTR1 O43613 4/20 0.35
HCRTR2 O43614 4/20 0.35
MEN1 O00255 3/20 0.34
RAD52 P43351 2/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10167504 0.86 KCNA5 (0.45) LMNATP53NPC1CASP3RAB9A
SCHEMBL10167481 0.86 HCRTR1 (0.34) LMNASMN1; SMN2KMT2AALDH1A1MAPT
SCHEMBL10167495 0.86 MEN1 (0.41) LMNARAB9ASMN1; SMN2KMT2AKDM4E
SCHEMBL10167555 0.84 KCNQ3 (0.36) RAB9ASMN1; SMN2KMT2AALDH1A1MEN1
SCHEMBL10167484 0.83 HCRTR1 (0.35) LMNARAB9ASMN1; SMN2KMT2AKDM4E
SCHEMBL10167485 0.83 HCRTR1 (0.33) LMNASMN1; SMN2ALDH1A1MAPTHCRTR1
SCHEMBL351412 0.81 PDE4A (0.34) LMNATP53RAB9ASMN1; SMN2KMT2A
SCHEMBL10167486 0.81 HCRTR1 (0.33) LMNATP53MAPTHCRTR1HCRTR2
SCHEMBL355401 0.81 HPGD (0.34) RAB9ASMN1; SMN2KMT2AKDM4EALDH1A1
SCHEMBL10167558 0.79 MAPT (0.49) KMT2AALDH1A1MAPTHCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119568-B2 3-amino-1,2-benzisothiazole compounds for combating animal pest II BASF SE (DE) 2012-02-21 US disclosed
US-8119568-B2 3-amino-1,2-benzisothiazole compounds for combating animal pest II BASF SE (DE) 2012-02-21 US disclosed
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BASF SE (DE) 2010-01-14 US disclosed
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BASF SE (DE) 2010-01-14 US disclosed
WO-2008090048-A2 3-AMINO-1,2-BENZISOTHIAZOLE COMPOUNDS FOR COMBATING ANIMAL PEST II BASF SE (DE) 2008-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BPNT1, BCAT1, TGFBR1 LMNA 4034/4885TP53 4256/4885NPC1 2906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.